CLIA / CAP Services

Eremid’s Clinical Laboratory is both CLIA-Certified (Clinical Laboratory Improvement Amendments) and CAP-Accredited (College of American Pathologists), and is dedicated to analyzing human clinical samples using cutting-edge technology.

Eremid’s high-complexity CLIA-certified, CAP-accredited clinical genomics lab serves clinical clients with best-in-class genomics analysis. Managed by ASPC (American Society of Clinical Pathology)-certified technologists in molecular biology, and working to CAP standards means we exceed the requirements for CLIA, delivering the exceptional quality data and service required to progress products in human health and longevity. 

Eremid Genomic Services CAP Accreditation Certificate


About CLIA certification:

CLIA-certified laboratories like Eremid’s (CLIA ID Number 34D2269577) are inspected, managed, and regulated by the Centers for Medicare and Medicaid Services, as mandated by US Code of Federal Regulations (CFR 42 Part 493.2). Meeting the standards for certification ensures CLIA-certified laboratories offer a superior level of accuracy, reliability, and consistency in clinical assays conducted.

About CAP accreditation:

CAP partners with laboratories, fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. CAP inspectors examine laboratories like Eremid’s (CAP ID Number 9611624) for laboratory records and quality control procedures, as well as staff qualifications, equipment, facilities, safety program, and overall management. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes.

Contact us to learn more or discuss a project with us today.

Looking for deeper insights on your next project? Discuss a project
"Eremid provides the support we need to make a global impact in our large immunogenomic oncology clinical studies. The team’s expertise and flexibility from assay design to data delivery is helping us achieve our vision – an ideal research partner." Geoffrey Erickson, Immunis AI, MI USA — Senior Vice President, Corporate Development
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO
Trusted by